<?xml version="1.0" encoding="UTF-8"?>
<p id="Par27">The traditional role of radiotherapy in patients who have metastatic cancer has been for palliation of symptomatic metastases where systemic therapy does not penetrate (i.e. brain metastases) [
 <xref ref-type="bibr" rid="CR5">5</xref>], or targetable sites of disease causing symptoms such as pain, obstruction and/or bleeding [
 <xref ref-type="bibr" rid="CR6">6</xref>â€“
 <xref ref-type="bibr" rid="CR8">8</xref>]. The doses of radiation used for palliation are typically low, utilizing simple radiation planning techniques with the goal of obtaining symptom relief while minimizing treatment toxicity as well as financial toxicity and treatment burden.
</p>
